Condition: Prostate Cancer

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT07184957

Sponsor: NYU Langone Health

Phase:

Eligibility:

• Age: minimum 40 Years maximum 85 Years
• Gender: Male

Inclusion Criteria:

• Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
• Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.

Exclusion Criteria:

• Men that are not diagnosed with prostate cancer.
• Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.

View trial on ClinicalTrials.gov